|
 |
Humulin RThis page contains recent news articles, when available, and an overview of Humulin R but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.DANBURY, Conn., July 16 /PRNewswire-FirstCall/ -- Biodel Inc. today announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete, ... RedOrbit Halozyme Therapeutics Announces Phase I Clinical Trial Results … - Jun 9, 2008 The CV for Tmax was reduced by 54% for Humalog and 12% for Humulin R. ... The insulin Tmax for Humulin R with rHuPH20 was 43% shorter than for Humalog alone ... Lifescience-online Clinician Presents Generex Oral-Lyn(TM) Clinical Data at the Pediatric... - May 2, 2006 Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that Dr. Jaime Guevara-Aguirre, MD, ... RedOrbit Press Release: Halozyme Therapeutics Announces Phase I Clinical Trial... - Jun 9, 2008 The data showed that combining the company's proprietary recombinant human hyaluronidase enzyme (rHuPH20) with Humulin R(R) (regular insulin human) or ... Pay-Per-View - PR Newswire - HighBeam Research Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the... - Sep 18, 2007 DANBURY, Conn., Sept. 18 /PRNewswire-FirstCall/ -- Biodel Inc. today announced additional clinical data from its VIAject(TM) program at the 43rd Scientific ... $4.95 - PR Newswire - ECNext Lilly's Withdrawal of Human Insulin Has Veterinary Ramifications;... - Sep 8, 2005 Eli Lilly and Company's forthcoming discontinuation of four human insulin products has surprised an unlikely group of doctors -- veterinarians -- as they ... RedOrbit Press Release: Biodel Inc. Announces VIAject(TM) Phase II Meal Study ... - Sep 18, 2007 Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Generex Biotechnology Presents Oral Insulin Clinical … - Sep 14, 2005 Generex Biotechnology Presents Oral Insulin Clinical Data At The 41st Annual Meeting of the European Association for the Study of Diabetes. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research … Color Differentiation System for Humalog(R) and Humulin(R) U-100... - Oct 27, 2008 Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Targanta Announces Additions to Management Team. - Aug 24, 2006 INDIANAPOLIS and ST. LAURENT, Quebec, Aug. 24 /PRNewswire/ -- Targanta Therapeutics, a privately held biopharmaceutical company developing antibacterial ... $4.95 - PR Newswire - ECNext Generex Biotechnology Presents Oral Insulin Clinical Data At The 41st... - Sep 14, 2005 TORONTO, Sept. 14 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation , a leader in the area of buccal drug delivery, today announced clinical trial ... $4.95 - PR Newswire - ECNext Press Release: Biodel Inc. Announces VIAject(TM) Data at Oral … - Jun 22, 2007 Biodel Inc. Announces VIAject(TM) Data at Oral Presentation at the American Diabetes Association Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With … - Nov 3, 2008 Halozyme conducted a Phase 1 euglycemic clamp study in 26 volunteer subjects who received an injection of Humulin R or Humalog with and without rHuPH20. ... RedOrbit Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin ... - Jun 25, 2007 In the type 1 diabetes study, patients' plasma insulin levels peaked sooner with Nasulin than with the very rapid acting Humalog and Humulin R (20 vs. ... Free with registration - Business Wire - AccessMyLibrary.com Halozyme Therapeutics Reports 2008 Second Quarter Financial Results - Aug 8, 2008 The data showed that combining the Company's proprietary recombinant human hyaluronidase enzyme (rHuPH20) with Humulin R(R) (regular insulin human) or ... RedOrbit Press Release: Halozyme Therapeutics Begins Phase 2 Clinical Trial of... - Nov 3, 2008 Halozyme conducted a Phase 1 euglycemic clamp study in 26 volunteer subjects who received an injection of Humulin R or Humalog with and without rHuPH20. ... Pay-Per-View - PR Newswire - HighBeam Research Family seeks $50M in wrongful death suit - Dec 7, 2006 Also diabetic, Kraig Scofield was with his brother in December 2005 when Keith Scofield went to Wal-Mart to buy Humulin R (u-100), a drug available without ... Frederick News Post - Frederick News Post (subscription) U500 insulin: a potential safety issue - Sep 8, 2008 Humulin R is the brand name for Eli Lilly's recombinant human regular insulin. ... The usual version of Humulin R is U-100; that is, 100 units of insulin ... HealthCentral.com Generex Biotechnology Presents Oral-lyn(TM) Clinical Trial Results. - Jun 14, 2005 TORONTO, June 14 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation , a leader in the area of buccal drug delivery, today announced clinical trial ... $4.95 - PR Newswire - ECNext Wal-Mart settles lawsuit alleging wrong drug caused Maryland man's … - Jul 12, 2007 Instead, he was given Humulin R (u-500), a drug available by prescription only that contains five times the insulin of the requested medication, ... $2.95 - Associated Press Archive - NewsBank Press Release: Generex Biotechnology Presents Oral-lyn(TM) Clinical … - Jun 14, 2005 Generex Biotechnology Presents Oral-lyn(TM) Clinical Trial Results. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Halozyme Therapeutics Reports 2008 Second Quarter … - Aug 8, 2008 The data showed that combining the Company's proprietary recombinant human hyaluronidase enzyme (rHuPH20) with Humulin R(R) (regular insulin human) or ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Brian JG Pereira, MD Joins Biodel's Board of Directors.... - Nov 21, 2007 Brian JG Pereira, MD Joins Biodel's Board of Directors. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Biodel Inc. Plans Relocation to New Headquarters... - Jul 27, 2007 Biodel Inc. Plans Relocation to New Headquarters within Danbury, CT. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research American ginseng. - Aug 1, 2006 What is it? American ginseng is an herbal medicine used to increase physical and mental well being. It may also be used to treat high blood sugar. ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com Pharmacokinetics of insulin aerosols generated by a capillary aerosol... - Feb 1, 2008 Formulation A was a 1.8%w/v insulin aqueous solution (1.6 IU/kg), Formulation B was the commercial Humulin R formulation (3.8 IU/kg) and Formulation C was a ... $9.94 - Pharmaceutical Technology Europe - Alacra Store Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS for … - Oct 19, 2006 INDIANAPOLIS, Oct. 19 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced financial results for the third quarter of 2006. ... RedOrbit Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales... - Apr 16, 2007 INDIANAPOLIS, Ind., April 16 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced strong financial results for the first quarter of 2007 and ... Free with registration - PR Newswire - AccessMyLibrary.com FDA posts list of potential problem drugs - Sep 6, 2008 Humulin R (U-500), insulin for diabetes, dosing confusion. -- Stromectol and Warfarin, an anti-parasite drug and a blood thinner, drug interaction. ... San Francisco Chronicle Surrogate estimates of insulin sensitivity in subjects with hypertensi... - Jul 4, 2006 17 All subjects were infused with regular insulin (Humulin-R, Lilly, IN, USA; 25 mU/min-m 2 ) and glucose (TAIYU, Shin-Tzu, Taiwan; 240 mg/min-m 2 ... Nature.com Article: Eli Lilly Abandons Prince William Project; Manassas Insulin... - Jan 12, 2007 Eli Lilly Abandons Prince William Project; Manassas Insulin Plant Would Have Had 350 Jobs; Half-Finished Building to Be Torn Down ... find The Washington ... Pay-Per-View - Washington Post - HighBeam Research Lilly Reports Solid First-Quarter Results - Apr 21, 2008 INDIANAPOLIS , April 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2008. ... Genetic Engineering News - Genetic Engineering News (press release) Article: Setbacks Change Pr. William Back to Pumpkin for Some - The … - Mar 9, 2007 Setbacks Change Pr. William Back to Pumpkin for Some ... find The Washington Post articles. So much for the Jag dealership, the Presidents Cup, ... Pay-Per-View - Washington Post - HighBeam Research Press Release: Targanta Announces Additions to Management Team. - … - Aug 24, 2006 Targanta Announces Additions to Management Team. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Alba Therapeutics Announces Upcoming Trials in Celiac Disease and the... - Dec 23, 2005 BALTIMORE, Dec. 23 /PRNewswire/ -- Alba Therapeutics Corporation ("Alba"), today announced its upcoming clinical trials for AT-1001 and also ... $4.95 - PR Newswire - ECNext Article: Eli Lilly's Pullout Leaves Shock Waves - The Washington Post... - Jan 18, 2007 Eli Lilly's Pullout Leaves Shock Waves ... find The Washington Post articles. When pharmaceutical giant Eli Lilly decided that it would shutter its ... Pay-Per-View - Washington Post - HighBeam Research Press Release: SemBioSys Reports Positive Preclinical Results of... - Nov 28, 2005 SemBioSys Reports Positive Preclinical Results of Plant Produced Insulin In the Plant Biotechnology Journal. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Free Medicine Foundation Helps Diabetics Receive Prescription … - Dec 13, 2006 Glucophage, Glucotrol, Glucovance, Glyburide, Insulin, Humalog, Human Insulin, Humulin 50/50, Humulin 70/30, Humulin Insulin, Humulin N, Humulin R, ... prleap.com Lilly Delivers Strong Third-Quarter Results. - Oct 18, 2007 INDIANAPOLIS, Oct. 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced strong financial results for the third quarter of 2007 and raised its ... $4.95 - PR Newswire - ECNext Press Release: Generex Biotechnology & University Campus Bio-Medico … - Apr 19, 2005 Generex Biotechnology & University Campus Bio-Medico Announce Publication Of Oral Insulin Research Study; Study shows Oral-lyn(TM) Controls Blood Glucose ... Pay-Per-View - PR Newswire - HighBeam Research Lilly Reports Strong Second-Quarter Results; Raises Full-Year Sales... - Jul 24, 2007 INDIANAPOLIS, July 24 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced strong financial results for the second quarter of 2007 and raised its ... $4.95 - PR Newswire - ECNext Deseret News, The : List of medications with potential safety problems - Sep 7, 2008 Humulin R (U-500), insulin for diabetes, dosing confusion. • Stromectol and Warfarin, an anti-parasite drug and a blood thinner, drug interaction. ... $2.95 - Deseret News - NewsBank Stocks to Watch: Wind River, Generex Biotechnology, Santarus. - Jun 14, 2005 Wind River (Nasdaq: WIND) The Eclipse Foundation, an open source community committed to the development of a universal development platform, and Wind River, ... $4.95 - M2 Presswire - ECNext Drugs in Sport: 5 Doping Scandal Predictions for 2006 - Jan 3, 2006 Both GH and insulin (Humulin R) are very small molecules (GH is composed of 191 amino acids, Insulin has only 51) that are injected subcutaneously, ... RunnersWeb List of medications with potential safety problems | Article from... - Sep 7, 2008 Humulin R (U-500), insulin for diabetes, dosing confusion. -- Stromectol and Warfarin, an anti-parasite drug and a blood thinner, drug interaction. ... Pay-Per-View - Deseret News - HighBeam Research Press Release: Lilly Reports Strong First-Quarter Results; Raises... - Apr 16, 2007 Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales and EPS Guidance. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Generex Biotechnology Presents Clinical Trial Results at Scientific … - Oct 4, 2005 TORONTO, Oct. 4 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced ... biotech-intelligence.com Refrigerating Insulin and Byetta - Aug 21, 2006 Likewise for the older Humulin R insulin. If you can't refrigerate it, you just need to keep it below 86 degrees Fahrenheit and away from heat and light. ... HealthCentral.com Biodel Announces Publications Demonstrating Superior Metabolic... - Jul 23, 2008 Biodel Inc. (Nasdaq: BIOD) announced today the publication of positive findings from studies demonstrating the superior metabolic profile of VIAject(TM) ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: LILLY (ELI) & COMPANY - 1st Quarter Results.(Financial... - Apr 16, 2007 LILLY (ELI) & COMPANY - 1st Quarter Results.(Financial report) from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Press Release: Lilly Reports Solid First-Quarter Results. - PR... - Apr 21, 2008 Lilly Reports Solid First-Quarter Results. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research ADA: A Skin Patch for Insulin Delivery - Jun 13, 2006 Dr. Heinemann and colleagues applied patches containing 150 U of Humulin R U-500 (human insulin) to the radio-frequency treated forearms of five healthy ... Diabetes In Control Press Release: Lilly Reports Solid Second-Quarter Results. - PR … - Jul 24, 2008 Lilly Reports Solid Second-Quarter Results. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: Heat and Control Inc.(new manufacturing facility in opened … - Jun 1, 2005 Heat and Control Inc.(new manufacturing facility in opened Nanjing, China) ... find Food & Drug Packaging articles. Heat and Control Inc. has opened a new ... Pay-Per-View - Food & Drug Packaging - HighBeam Research Secondary lines require "primary" attention.(ISMP Canada) - Dec 22, 2006 It was decided that the best course of action would be to temporarily stop the infusion of insulin (Humulin R 100 units in 100mL). The nurse piggybacked the ... Free with registration - Dynamics - AccessMyLibrary.com WTHR |Two Eli Lilly drugs on FDA warning list - Sep 5, 2008 Entertainment News from AP. Washington - When a popular medicine begins causing dangerous reactions in patients, the federal government is alerted. ... WTHR Kansas Regulations - 129-5-1. Prior authorization. - Nov 3, 2005 ...and (I) pramlintide acetate; (35) the following types of syringes, penfills, and cartridges of insulin: (A) Humalog® (B) Humalog Mix® (C) Humulin R® (D) ... Pay-Per-View - Kansas Regulations - Loislaw Nasulin(TM) Interim Results to Be Presented at American Diabetes … - Apr 10, 2007 Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin(TM)), Injectable Regular Insulin (Humulin R(R)), Injectable Fast-Acting Insulin (Humalog(R)), ... Genetic Engineering News - Genetic Engineering News (press release) A Closer Look at Bentley Pharmaceuticals Inc. - Apr 13, 2007 Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin(TM)), Injectable Regular Insulin (Humulin R(R)), Injectable Fast-Acting Insulin (Humalog(R)), ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: Biodel Inc. (Nasdaq: BIOD) just released some important... - Sep 8, 2008 Biodel Inc. (Nasdaq: BIOD) just released some important news. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Lilly Announces Individual Bar Coding on All Insulin... - Feb 7, 2005 Lilly Announces Individual Bar Coding on All Insulin Vials; Industry believes bar codes may reduce risk of medication errors in hospital settings. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Article: Verify linear bar codes.(PRODUCTS OF THE MONTH) - Material … - Sep 1, 2006 Verify linear bar codes.(PRODUCTS OF THE MONTH) ... find Material Handling Product News articles. For validating the readability and standards compliance of ... Pay-Per-View - Material Handling Product News - HighBeam Research Biodel (BIOD) Reports Preliminary Results from Phase III Trials for... - Sep 8, 2008 Biodel Inc. (Nasdaq: BIOD) today reported results from its two pivotal Phase III clinical trials designed to compare the efficacy and safety of VIAject(TM) ... StreetInsider.com - StreetInsider.com (subscription) Biodel Expands Ongoing Phase III VIAject Clinical Trials Into Europe - Sep 25, 2007 ...and the other enrolling 400 patients with Type 2 diabetes, are comparing the effects of VIAject and Humulin R, the leading recombinant human insulin. ... FDA news - FDA news (subscription) Type 2 Diabetes and Insulin - Jan 8, 2008 The oldest type of short-acting insulin is Regular insulin (Humulin R and Novolin R). It lasts about 6–8 hours and has its peak about 2 hours after ... Diabetes Self Management Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials... - Sep 21, 2007 DANBURY, Conn., Sept. 21 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has expanded its two ongoing pivotal Phase ... Genetic Engineering News - Genetic Engineering News (press release) New Insulin Manufacturer Enters the Diabetes Arena - Jan 15, 2008 We will soon have even more choices. Biodel Inc. completes enrollment of two pivotal phase III clinical trials of VIAject and plans manufacturing facility ... Diabetes In Control Learn about Insulin Injection from Consumer Reports Health. - Jan 7, 2007 If you are using a regular insulin (Humulin R, Novolin R), the insulin should be as clear, colorless, and fluid as water. Do not use this type of insulin if ... consumerreports.org Biodel Inc. Receives Notice Of Issuance For US Patent Covering Lead … - Sep 28, 2007 Biodel Inc. (Nasdaq: BIOD) announced the receipt of a notice of issuance from the United States Patent and Trademark Office (USPTO) for the Company's patent ... Medical News Today - Medical News Today (press release) Erie Times-News : State<br> - Sep 6, 2008 Humulin R (U-500), insulin for diabetes, dosing confusion. • Stromectol and Warfarin, an anti-parasite drug and a blood thinner, drug interaction. ... $2.95 - Erie Times-News - NewsBank Press Release: Stocks to Watch: Wind River, Generex Biotechnology, … - Jun 14, 2005 Stocks to Watch: Wind River, Generex Biotechnology, Santarus. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Kellogg Reports Double-Digit EPS Growth and Raises … - Jan 31, 2006 Kellogg Reports Double-Digit EPS Growth and Raises Guidance. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Biodel Inc. Expands Ongoing Phase III VIAject(TM) … - Sep 21, 2007 Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Pfizer Inc. Review in Progress. - M2 Presswire | … - Apr 9, 2008 Diamyd Medical- Eli Lilly- Exubera- Humalog- Humulin R- Lantus ... Nordisk- Novolin R- NovoLog- Pfizer- Prograf- Rapamune- Roche ... ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Lilly to Streamline Indianapolis Manufacturing and … - Apr 16, 2008 Lilly to Streamline Indianapolis Manufacturing and Engineering Operations. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research SemBioSys' plant-produced insulin chemically and physiologically … - Jan 10, 2007 CALGARY , Jan. 10 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a broad pipeline of protein-based ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: Pfizer cancer drug proved safe and Corixa receives … - Feb 9, 2005 Pfizer cancer drug proved safe and Corixa receives Hepatitis B vaccine approval. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Press Release: FDA approves Prograf to prevent rejection of heart … - Mar 31, 2006 Exubera- Humalog- Humulin R- Lantus- Neuroendocrine Biosciences- Novartis- Novo Nordisk- Novolin R- NovoLog- Pfizer- Prograf- Rapamune- Roche- ... Pay-Per-View - M2 Presswire - HighBeam Research Bentley Late Breaking Abstract Accepted for Poster Presentation at … - May 24, 2007 Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin™), Injectable Regular Insulin (Humulin R®), Injectable Fast-Acting Insulin (Humalog®), ... RedOrbit SemBioSys' Plant-Produced Insulin Chemically and Physiologically … - Oct 1, 2007 SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a broad pipeline of protein-based pharmaceuticals and non-pharmaceutical products, ... presseportal.de Biodel Reports Protective Effects of VIAject(TM) Insulin on Microvascu... - Nov 15, 2008 Biodel Inc. (Nasdaq: BIOD) today reported positive effects of VIAject™ insulin on microvascular function in patients with Type 2 diabetes which were ... Genetic Engineering News - Genetic Engineering News (press release) Biodel receives notice of issuance for United States patent covering... - Oct 1, 2007 VIAject is currently being tested in two pivotal Phase III clinical trials, which are comparing the effects of VIAject to Humulin R, the leading recombinant ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com New insulins in the management of diabetes.(CONTINUING EDUCATION … - Nov 19, 2007 Regular diluent is intended for use with insulin regular (Humulin R). NPH diluent is intended for use with insulin lispro (Humalog); 25% insulin lispro and ... Free with registration - Drug Topics - AccessMyLibrary.com Introducing the Brand New Report on Business Strategies for Different... - Dec 6, 2007 Granocyte/Neutrogin - Grastim - Hematide - Humalog - Humatrope - Humulin N - Humulin R - Humulin U - Infergen - Infergen/Advaferon - Intron-A - Lantus ... Free with registration - Business Wire - AccessMyLibrary.com Diabetes - Biodel Announces Preliminary Results Of Pivotal Phase III ... - Sep 9, 2008 At the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Rome, Biodel Inc. (Nasdaq: BIOD) reported results from its two ... Medical News Today - Medical News Today (press release) Press Release: Neuromed Receives Milestone Payment of $2 Million … - Mar 14, 2007 Neuromed Receives Milestone Payment of $2 Million Under Collaboration and License Agreement with Merck & Co., Inc. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Biodel receives notice of issuance for United States patent covering... - Oct 1, 2007 VIAject is currently being tested in two pivotal Phase III clinical trials, which are comparing the effects of VIAject to Humulin R, the leading recombinant ... Pay-Per-View - BIOTECH Patent News - HighBeam Research Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical... - Jan 3, 2008 DANBURY, Conn., Jan. 3 /PRNewswire-FirstCall/ -- Biodel Inc. today announced that the Company has completed enrollment of its two pivotal Phase III clinical ... $4.95 - PR Newswire - ECNext Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials... - Sep 21, 2007 DANBURY, Conn., Sept. 21 /PRNewswire-FirstCall/ -- Biodel Inc. today announced that the Company has expanded its two ongoing pivotal Phase III clinical ... $4.95 - PR Newswire - ECNext Press Release: SemBioSys Submits IND for Safflower-Produced Insulin... - Jul 29, 2008 SemBioSys Submits IND for Safflower-Produced Insulin to US FDA. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Neuromed Raises US$53.3 Million in Series E Financing ... - Aug 21, 2007 Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: SemBioSys submits IND for safflower-produced insulin... - Jul 29, 2008 SemBioSys submits IND for safflower-produced insulin to US FDA. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: SemBioSys to proceed with abbreviated regulatory path ... - Jan 3, 2007 SemBioSys to proceed with abbreviated regulatory path for plant-produced insulin after meeting with the FDA. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Biodel Inc. Completes Enrollment of Two Pivotal Phase... - Jan 3, 2008 Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: SemBioSys to Proceed With Abbreviated Regulatory Path … - Jan 3, 2007 SemBioSys to Proceed With Abbreviated Regulatory Path for Plant-Produced Insulin After Meeting With the FDA. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Biodel Inc. Announces the Completion of Its Two... - Jul 16, 2008 Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Biodel Inc. Receives Notice of Issuance for US Patent ... - Sep 27, 2007 Biodel Inc. Receives Notice of Issuance for US Patent Covering Lead Product Candidates VIAject(TM) and VIAtab(TM). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Progress Review For Biodel Inc. - Jun 19, 2007 M2 PRESSWIRE-19 June 2007-www.streetinvesting.com: Progress Review For Biodel Inc.(C)1994-2007 M2 COMMUNICATIONS LTD. Please visit www. ... $4.95 - M2 Presswire - ECNext Batalia o tańsze insuliny - Jan 25, 2005 ...za Humulin R Pen roztwór do wstrzykiwań 100 jm 5 wstrzykiwaczy po 3 ml - 36,35 zł (obecnie 20,30 zł), a za Mixtard 50 NovoLet zawiesina do wstrzykiwań ... NaszeMiasto.pl Press Release: Kellogg Reports Strong Results in 2004. - PR Newswire... - Jan 31, 2005 Kellogg Reports Strong Results in 2004. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |